Observational studyCerebellum (London, England)2026
Longitudinal Changes and Responsiveness of the Cerebellar Cognitive Affective Syndrome Scale in Patients with Acute Cerebellar Stroke.
Observational study in Cerebellum (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive and affective disturbances due to cerebellar lesions are termed cerebellar cognitive affective syndrome (CCAS). Although CCAS is frequent after acute cerebellar stroke, CCAS-Scale responsiveness during acute hospitalization remains unclear. Objective: To examine longitudinal changes and responsiveness of the CCAS-Scale and compare its changes with global cognitive function, ataxia, and activities of daily living (ADL). In this single-center prospective observational study, 21 patients with first-ever cerebellar stroke were assessed 7 days after onset and at discharge (median, 21 days) using the CCAS-Scale, Mini-Mental State Examination (MMSE), Scale for the Assessment and Rating of Ataxia (SARA), and Functional Independence Measure (FIM). Changes were analyzed using the Wilcoxon signed-rank test, standardized response mean (SRM), and Spearman's rank correlation. Median CCAS-Scale score increased from 71 to 72 (p = 0.018), and failed items decreased from 4 to 3 (p = 0.035). Definite CCAS decreased from 81.0% to 66.7%, and all patients had at least possible CCAS at discharge. The SRM was 0.52 (95% CI, 0.20-0.88), indicating moderate responsiveness, whereas SARA and FIM showed large and MMSE small responsiveness. CCAS-Scale change correlated with FIM change (rho = 0.44; p = 0.046) but not with SARA or MMSE. The CCAS-Scale showed a statistically significant change and moderate responsiveness. However, the median score increased by only 1 point (71 to 72), and the 95% CI for the SRM was relatively wide, suggesting that the clinical significance of this change should be interpreted cautiously.
Indexed as
Identifiers
42918963What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.